Iressa 250mg
Gefitinib, also known by its brand name Iressa, is a targeted therapy medication used in the treatment of non-small cell lung cancer (NSCLC). The active ingredient, Gefitinib/IRESSA, works by blocking the action of a protein called epidermal growth factor receptor (EGFR), which is overactive in some types of cancer cells. By inhibiting EGFR, Gefitinib/IRESSA helps slow down or stop the growth of cancer cells, leading to improved outcomes for patients with NSCLC. Gefitinib/IRESSA is available in tablet form and is typically taken orally once a day on an empty stomach. It is important to follow the dosing instructions provided by your healthcare provider to ensure the optimal effectiveness of the medication. As with any cancer therapy, Gefitinib/IRESSA may cause side effects, including skin rash, diarrhea, nausea, and liver function abnormalities. It is crucial to communicate any side effects to your healthcare team promptly for appropriate management.
For patients with NSCLC, Gefitinib/IRESSA represents a valuable treatment option that targets the underlying mechanisms driving cancer growth, offering hope and improved quality of life. Consult your healthcare provider to determine if Gefitinib/IRESSA is the right choice for your cancer treatment plan.
Frequently Asked Questions (FAQ) About Gefitinib/IRESSA:
1: What is Gefitinib/IRESSA?
Gefitinib/IRESSA is a targeted therapy medication used in the treatment of non-small cell lung cancer (NSCLC). It works by inhibiting the action of epidermal growth factor receptor (EGFR) in cancer cells, slowing down or stopping their growth.
2: How is Gefitinib/IRESSA taken?
Gefitinib/IRESSA is typically taken orally as a tablet, usually once a day on an empty stomach. It is essential to follow the dosing instructions provided by your healthcare provider for optimal treatment outcomes.
3: What are the common side effects of Gefitinib/IRESSA?
Common side effects of Gefitinib/IRESSA may include skin rash, diarrhea, nausea, and abnormalities in liver function. It is important to report any side effects to your healthcare team for proper management.
4: Is Gefitinib/IRESSA suitable for everyone with NSCLC?
Gefitinib/IRESSA is recommended for patients with NSCLC whose cancer cells have certain mutations in the EGFR gene. Your healthcare provider will determine if Gefitinib/IRESSA is the right treatment option for your specific condition.
5: Can Gefitinib/IRESSA be taken with other medications?
It is important to inform your healthcare provider about all medications you are taking, including prescription, over-the-counter, and herbal supplements, to avoid potential drug interactions with Gefitinib/IRESSA.
Why Choose Republic Pharma for Buying Gefitinib/IRESSA:
Republic Pharma is a trusted pharmaceutical company known for its commitment to quality, reliability, and patient-centered care. When considering where to purchase Gefitinib/IRESSA, here are some reasons to prefer buying from Republic Pharma:
- Quality Assurance:- Republic Pharma adheres to stringent quality standards in the manufacturing and distribution of pharmaceutical products, ensuring that Gefitinib/IRESSA meets high-quality specifications for safety and efficacy.
- Reliability and Consistency:- Republic Pharma has a reputation for reliable supply chain management and consistent availability of medications, including Gefitinib/IRESSA, to ensure that patients receive their treatment without interruptions.
- Patient Support Services:- Republic Pharma provides comprehensive patient support services, including information on medication use, side effect management, and access to resources for patients undergoing cancer treatment with Gefitinib/IRESSA.
- Professional Guidance:- Republic Pharma's team of healthcare professionals and pharmacists is dedicated to providing guidance and support to patients, caregivers, and healthcare providers, ensuring that individuals have the information they need to make informed decisions about their treatment.
- Commitment to Patient Care:- Republic Pharma prioritizes patient care and satisfaction, striving to enhance the treatment experience for individuals using Gefitinib/IRESSA and other medications, fostering a sense of trust and confidence in the pharmaceutical products provided.
By choosing Republic Pharma for your Gefitinib/IRESSA purchase, you can benefit from a reliable and patient-focused pharmaceutical provider dedicated to ensuring the well-being and treatment success of individuals battling NSCLC.
| Country of Manufacture | India |
|---|---|
| Manufacturer | GSK |